Pasvolsky, Oren
Wang, Zhongya
Milton, DenĂ¡i R.
Tanner, Mark R.
Bashir, Qaiser
Srour, Samer
Saini, Neeraj
Lin, Paul https://orcid.org/0000-0002-0524-267X
Ramdial, Jeremy
Nieto, Yago
Tang, Guilin https://orcid.org/0000-0002-9482-4806
Kebriaei, Partow
Aljawai, Yosra
Khan, Hina N.
Lee, Hans C. https://orcid.org/0000-0001-8545-3292
Ye, Christine
Patel, Krina K. https://orcid.org/0000-0002-8894-027X
Thomas, Sheeba K.
Orlowski, Robert Z.
Shpall, Elizabeth J.
Champlin, Richard E.
Qazilbash, Muzaffar H. https://orcid.org/0000-0003-2876-2886
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 11 March 2024
Revised: 23 April 2024
Accepted: 25 April 2024
First Online: 17 May 2024
Competing interests
: HCL reports consulting fees: Abbvie, Bristol Myers Squibb, Genentech, Janssen, Regeneneron, GlaxoSmithKline, Sanofi, Takeda Pharmaceuticals, Allogene Therapeutics; Research Funding: Amgen, Bristol Myers Squibb, Janssen, GlaxoSmithSkine, Regeneron, Takeda Pharmaceuticals. All other authors have not declared a conflict of interest.